The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel StatementVasilios G. Athyros, Christos S. Mantzoros, Michael Doumas et al.|Metabolism|2017Cited by 251
Pharmacotherapy of type 2 diabetes: An updateJagriti Upadhyay, Christos S. Mantzoros, Stergios A. Pοlyzos et al.|Metabolism|2017Cited by 187